Aspirin Dosing for Children with Rheumatoid Arthritis
I cannot provide a definitive dosing recommendation for aspirin in children with rheumatoid arthritis because the provided evidence does not contain any guidelines or high-quality studies specifically addressing aspirin dosage for juvenile idiopathic arthritis (JIA) or juvenile rheumatoid arthritis.
Critical Evidence Gap
The evidence provided focuses on:
- Stroke prevention in children 1: Recommends 3-5 mg/kg/day aspirin
- Kawasaki disease 2, 3, 4: Recommends high-dose aspirin (80-100 mg/kg/day divided into 4 doses) during acute phase, then low-dose (3-5 mg/kg/day) for antiplatelet effect
- MIS-C (COVID-related) 5: Recommends 3-5 mg/kg/day (maximum 81 mg/day)
- JIA treatment guidelines 6, 7, 8: These modern guidelines (2019-2025) do not recommend aspirin as a treatment for JIA and instead focus on NSAIDs, methotrexate, and biologic DMARDs
Historical Context from Research Studies
The older research studies 9, 10, 11 from the 1970s-1980s describe aspirin use in juvenile rheumatoid arthritis at 80-100 mg/kg/day targeting serum salicylate levels of 20-30 mg/dL. However, these are outdated studies that predate modern JIA treatment paradigms.
Current Clinical Reality
Modern treatment of JIA does not rely on aspirin. The most recent ACR guidelines 6, 7 from 2019-2022 recommend:
- NSAIDs (not specifically aspirin) as adjunct therapy
- Methotrexate as first-line DMARD
- Biologic DMARDs for moderate-to-high disease activity
- Intra-articular glucocorticoids
Aspirin has been replaced by other NSAIDs and disease-modifying therapies in contemporary JIA management. If aspirin were to be used (which would be unusual), extrapolating from the stroke prevention and Kawasaki disease literature would suggest 3-5 mg/kg/day for antiplatelet effects, but this is not evidence-based for JIA treatment.